Search clinical trials for: Eribulin Injection [Halaven]
Total 9991 results
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
Eisai Co., Ltd.CompletedSarcoma, Soft TissueJapan
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTriple Negative Breast CancerChina
-
Massachusetts General HospitalEisai Inc.Active, not recruitingAngiosarcoma | Epithelioid HemangioendotheliomaUnited States
-
Oncologia Medica dell'Ospedale FatebenefratelliMario Negri Institute for Pharmacological ResearchCompletedMetastatic Breast Cancer | Toxicity | Neurotoxicity | Adverse Drug Event | Drug ToxicityItaly
-
Swiss Group for Clinical Cancer ResearchTerminatedAdenocarcinoma | Breast CancerSwitzerland
-
Eisai Inc.Completed
-
Chang Gung Memorial HospitalEisai Co., Ltd.; Kaohsiung Breast Cancer Prevention and Education Society (KBCPES)UnknownAdvanced Breast Cancer | Metastatic Breast CancerTaiwan
-
The First Affiliated Hospital with Nanjing Medical...RecruitingHER2-negative Breast CancerChina
-
MedSIRTerminated
-
Eisai Inc.Completed
-
Dana-Farber Cancer InstituteCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteEisai Inc.CompletedBreast CancerUnited States
-
University of OklahomaTerminatedLymphoma | Solid Tumors | Pediatric CancerUnited States
-
Imperial College LondonTerminatedBreast CancerUnited Kingdom
-
Eisai Korea Inc.CompletedLocally Advanced or Metastatic Breast CancerKorea, Republic of
-
MedSIRMenarini GroupRecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast CancerSpain
-
Institut fuer FrauengesundheitEisai GmbHRecruitingAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, BreastGermany
-
SOLTI Breast Cancer Research GroupEisai Inc.CompletedBreast CancerSpain, France, Portugal, Germany
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia and other collaboratorsCompletedMetastatic Breast CancerSpain, United Kingdom
-
Prof. W. JanniActive, not recruitingHER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female PatientsGermany
-
Hope Rugo, MDSusan G. Komen Breast Cancer Foundation; PlexxikonCompletedMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Vector OncologyEisai Inc.TerminatedHER-2 Positive Breast CancerUnited States
-
SCRI Development Innovations, LLCEisai Inc.CompletedMetastatic Breast CancerUnited States
-
Beijing 302 HospitalRecruitingTNBC - Triple-Negative Breast CancerChina
-
Monika Joshi, MDPfizer; Eisai Inc.; Big Ten Cancer Research ConsortiumTerminatedMetastatic Urothelial Cell CancerUnited States
-
MedSIRCompleted
-
Eisai Inc.Merck Sharp & Dohme LLCCompleted
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCActive, not recruitingSarcoma | Leiomyosarcoma | Liposarcoma | Undifferentiated Pleomorphic SarcomaUnited States
-
National Taiwan University HospitalTaipei Veterans General Hospital, TaiwanActive, not recruitingAdvanced Cancer | Leiomyosarcoma | Soft Tissue Sarcoma Adult | LiposarcomaTaiwan
-
Australia New Zealand Gynaecological Oncology GroupMerck Sharp & Dohme LLC; Eisai Inc.RecruitingUterine Carcinosarcoma | Ovarian CarcinosarcomaCanada, Australia, United Kingdom
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompleted
-
Eisai Inc.CompletedBreast Cancer | Estrogen Receptor Positive TumorUnited States
-
Virginia G. KaklamaniEisai Inc.Completed
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
The University of Texas Health Science Center at...WithdrawnCancer of the Breast
-
Zhejiang Cancer HospitalNot yet recruiting
-
Eisai Inc.CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
The University of Texas Health Science Center at...WithdrawnOvarian Cancer | Breast Cancer Stage IV | BRCA1 Mutation | BRCA2 Mutation
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
MedSIRWithdrawn
-
Eisai LimitedCompleted
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
University of California, San FranciscoEisai Inc.CompletedMalignant Solid Tumour | Breast Cancer Nos Metastatic Recurrent | NeuropathyUnited States
-
National Cancer Institute (NCI)CompletedRecurrent OsteosarcomaUnited States, Canada
-
Eisai LimitedCompletedAdvanced Solid TumorFrance
-
Eisai GmbHCompletedLocally Advanced or Metastatic Breast CancerGermany